ArriVent BioPharma, Inc.
AVBP· Nasdaq
ArriVent BioPharma, Inc.
- Last sale
- Oct 2, 2026 · -2.03%
- Market cap
- $1.40B
- 49.31M shares
- Filings
- 152
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $153,351,000 | reported | |
| FY 2024 | 2024-12-31 | $79,004,000 | reported | |
| FY 2023 | 2023-12-31 | $64,884,000 | reported |
ArriVent BioPharma, Inc. · CIK 1868279 · Engraved from SEC EDGAR
